TrialPain2022

Randomized, double-blind, placebo-controlled trial of ISC 17536, an oral inhibitor of transient receptor potential ankyrin 1, in patients with painful diabetic peripheral neuropathy: impact of preserved small nerve fiber function.

Sunil M Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.